The objectives of the Governor General’s Innovation Awards is to celebrate excellence in innovation across all sectors of Canadian society and inspire Canadians, particularly Canadian youth, to be entrepreneurial innovators. These innovation Awards is an ongoing national awards program, sustained through both public and private financial contributions and through the efforts of numerous organizations across Canada.
Dr. Shaf Keshavjee received this prestigious award for developing “The Toronto Ex Vivo Lung Perfusion (EVLP) System“. This system addressed the shortage of donor lungs needed for life-saving lung transplantation. Transplant surgeons can now objectively assess donor lung function outside of the body for extended periods and then confidently decide whether to use a donor lung for transplant. Since the first clinical trial in 2008, EVLP has been adopted around the world, saving hundreds of lives of patients with end-stage lung disease.
Dr. Shaf Keshavjee is a world-renowned thoracic surgeon and the Surgeon-in-Chief, Sprott Department of Surgery at University Health Network in Toronto. He is also the Director of the Toronto Lung Transplant Program and the Latner Thoracic Research Laboratories—the largest lung transplant research centre in the world.